# Safety, Tolerability and Pharmacokinetics of Felbinac Trometamol Eye Drops

> **NCT05085106** · PHASE1 · UNKNOWN · sponsor: **Beijing Tongren Hospital** · enrollment: 48 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Felbinac trometamol eye drop
- **DRUG:** Placebo eye drop

## Key facts

- **NCT ID:** NCT05085106
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-21
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05085106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05085106, "Safety, Tolerability and Pharmacokinetics of Felbinac Trometamol Eye Drops". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05085106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*